Minimal Residual Disease is A Vital Marker for Patients with Multiple Myeloma, Says Expert
Dr. Parameswaran Hari discusses the importance of understanding a patient’s MRD if they are receiving the maintenance therapy Sarclisa for multiple myeloma.
Read More